TENAX THERAPEUTICS, INC. Increase (Decrease) in Interest and Dividends Receivable
TENAX THERAPEUTICS, INC. (TENX) reported Increase (Decrease) in Interest and Dividends Receivable of -$4.07 thousand for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-11.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestAndDividendsReceivable · last filed 2022-08-11
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for the quarter ending 2022-06-30 was -$1.48K.
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for the quarter ending 2022-03-31 was -$2.59K.
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for the quarter ending 2021-12-31 was -$1.90K.
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for the quarter ending 2021-09-30 was $1.90K, a 211.15% increase year-over-year.
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for fiscal 2021 was -$949.00.
- TENAX THERAPEUTICS, INC. increase (decrease) in interest and dividends receivable for fiscal 2020 was -$1.63K.
| Period end | Increase (Decrease) in Interest and Dividends Receivable 3 month | Increase (Decrease) in Interest and Dividends Receivable 6 month | Increase (Decrease) in Interest and Dividends Receivable 6 month as first filed | Increase (Decrease) in Interest and Dividends Receivable 9 month | Increase (Decrease) in Interest and Dividends Receivable 9 month as first filed | Increase (Decrease) in Interest and Dividends Receivable 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | -$1.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$4.07K 10-Q · filed 2022-08-11 | -$5.97K derived: sum of 3 quarters · filed 2022-08-11 | -$4.07K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2022-03-31 | -$2.59K 10-Q · filed 2022-05-16 | -$4.49K derived: sum of 2 quarters · filed 2022-05-16 | -$2.59K derived: sum of 3 quarters · filed 2022-05-16 | -$2.92K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-12-31 | -$1.90K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $0.00 derived: sum of 2 quarters · filed 2022-03-29 | -$336.00 derived: sum of 3 quarters · filed 2022-08-11 | -$949.00 10-K · filed 2022-03-29 | ||
| 2021-09-30 | $1.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.56K derived: sum of 2 quarters · filed 2022-08-11 | $949.00 10-Q · filed 2021-11-15 | -$1.69K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-06-30 | -$336.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$949.00 10-Q · filed 2022-08-11 | $949.00 10-Q · filed 2021-08-16 | -$3.59K derived: sum of 3 quarters · filed 2022-08-11 | -$2.98K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$613.00 10-Q · filed 2022-05-16 | -$3.26K derived: sum of 2 quarters · filed 2022-05-16 | -$2.65K derived: sum of 3 quarters · filed 2022-05-16 | -$2.24K derived: sum of 4 quarters · filed 2022-05-16 | ||
| 2020-12-31 | -$2.64K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | -$2.03K derived: sum of 2 quarters · filed 2022-03-29 | -$1.63K derived: sum of 3 quarters · filed 2022-03-29 | -$1.63K 10-K · filed 2022-03-29 | ||
| 2020-09-30 | $610.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.02K derived: sum of 2 quarters · filed 2021-11-15 | $1.02K 10-Q · filed 2021-11-15 | -$1.02K 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $406.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $406.00 10-Q · filed 2021-08-16 | -$406.00 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-17 | |||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |